Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1990 1
2013 1
2014 2
2015 3
2016 2
2017 1
2018 2
2019 2
2020 4
2021 4
2022 5
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
A review on age-related cancer risks in PTEN hamartoma tumor syndrome.
Hendricks LAJ, Hoogerbrugge N, Schuurs-Hoeijmakers JHM, Vos JR. Hendricks LAJ, et al. Among authors: vos jr. Clin Genet. 2021 Feb;99(2):219-225. doi: 10.1111/cge.13875. Epub 2020 Nov 16. Clin Genet. 2021. PMID: 33140411 Free PMC article. Review.
Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort.
Hendricks LAJ, Hoogerbrugge N, Venselaar H, Aretz S, Spier I, Legius E, Brems H, de Putter R, Claes KBM, Evans DG, Woodward ER, Genuardi M, Brugnoletti F, van Ierland Y, Dijke K, Tham E, Tesi B, Schuurs-Hoeijmakers JHM, Branchaud M, Salvador H, Jahn A, Schnaiter S, Anastasiadou VC, Brunet J, Oliveira C, Roht L, Blatnik A, Irmejs A; PTEN Study Group; Mensenkamp AR, Vos JR. Hendricks LAJ, et al. Among authors: vos jr. Eur J Med Genet. 2022 Dec;65(12):104632. doi: 10.1016/j.ejmg.2022.104632. Epub 2022 Oct 18. Eur J Med Genet. 2022. PMID: 36270489 Free article.
Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome.
Hendricks LAJ, Hoogerbrugge N, Mensenkamp AR, Brunet J, Lleuger-Pujol R, Høberg-Vetti H, Tveit Haavind M, Innella G, Turchetti D, Aretz S, Spier I, Tischkowitz M, Jahn A, Links TP, Olderode-Berends MJW, Blatnik A, Leter EM, Evans DG, Woodward ER, Steinke-Lange V, Anastasiadou VC, Colas C, Villy MC, Benusiglio PR, Gerasimenko A, Barili V, Branchaud M, Houdayer C, Tesi B, Yazicioglu MO, van der Post RS, Schuurs-Hoeijmakers JHM; PTEN Study Group; Vos JR. Hendricks LAJ, et al. Among authors: vos jr. J Natl Cancer Inst. 2023 Jan 10;115(1):93-103. doi: 10.1093/jnci/djac188. J Natl Cancer Inst. 2023. PMID: 36171661 Free article.
Response to Tomao, Panici, and Tomao.
Vos JR, Ligtenberg MJL, Hoogerbrugge N. Vos JR, et al. J Natl Cancer Inst. 2020 Apr 1;112(4):425. doi: 10.1093/jnci/djz140. J Natl Cancer Inst. 2020. PMID: 31287552 Free PMC article. No abstract available.
Catch them if you are aware: PTEN postzygotic mosaicism in clinically suspicious patients with PTEN Hamartoma Tumour Syndrome and literature review.
Hendricks LAJ, Schuurs-Hoeijmakers J, Spier I, Haadsma ML, Eijkelenboom A, Cremer K, Mensenkamp AR, Aretz S, Vos JR, Hoogerbrugge N. Hendricks LAJ, et al. Among authors: vos jr. Eur J Med Genet. 2022 Jul;65(7):104533. doi: 10.1016/j.ejmg.2022.104533. Epub 2022 May 28. Eur J Med Genet. 2022. PMID: 35640862 Free article. Review.
The BRCA1/2 Parent-of-Origin Effect on Breast Cancer Risk-Response.
Vos JR, Oosterwijk JC, Rookus MA, van der Hout AH, Mourits MJ, de Bock GH; all authors. Vos JR, et al. Cancer Epidemiol Biomarkers Prev. 2017 Feb;26(2):285. doi: 10.1158/1055-9965.EPI-16-0947. Cancer Epidemiol Biomarkers Prev. 2017. PMID: 28167645 No abstract available.
32 results